Ruolan Dong
Impact in
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 10%
Papers in
-
- Eicosanoids and Hypertension Pharmacology 9
-
- Hormonal Regulation and Hypertension 6
- Diet, Metabolism, and Disease 3
- Co-authors
- Ling Tu (19 shared papers)Xizhen Xu (18 shared papers)Menglu Fu (14 shared papers)Dao Wen Wang (10 shared papers)Yan Yang (11 shared papers)Jinlan Luo (10 shared papers)Guang Chen (9 shared papers)Zhihui Chen (8 shared papers)
- Journals
- Cellular Physiology and Biochemistry (2 papers)Journal of Ethnopharmacology (2 papers)Frontiers in Pharmacology (2 papers)Biomedicine & Pharmacotherapy (2 papers)International Journal of Molecular Medicine (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ruolan Dong
33 papers receiving 790 citations
Peers
Comparison fields: 5 of 95
- Biochemistry 95
- Pharmacology 52
- Endocrinology, Diabetes and Metabolism 86
- Geriatrics and Gerontology 15
- Cancer Research 62
Countries citing papers authored by Ruolan Dong
This map shows the geographic impact of Ruolan Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolan Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolan Dong more than expected).
Fields of papers citing papers by Ruolan Dong
This network shows the impact of papers produced by Ruolan Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolan Dong. The network helps show where Ruolan Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruolan Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 79 | |
| 2 | 2020 | 73 | |
| 3 | 2020 | 62 | |
| 4 | 2020 | 47 | |
| 5 | 2020 | 45 | |
| 6 | 2013 | 40 | |
| 7 | 2015 | 40 | |
| 8 | 2013 | 34 | |
| 9 | 2021 | 33 | |
| 10 | 2021 | 31 | |
| 11 | 2014 | 29 | |
| 12 | 2019 | 28 | |
| 13 | 2023 | 23 | |
| 14 | 2020 | 21 | |
| 15 | 2017 | 20 | |
| 16 | 2021 | 20 | |
| 17 | 2020 | 19 | |
| 18 | 2018 | 17 | |
| 19 | 2015 | 16 | |
| 20 | 2019 | 15 |
About Ruolan Dong
Ruolan Dong is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism, Genetics, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 33 papers that have together received 801 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (9 papers), Hormonal Regulation and Hypertension (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Diet, Metabolism, and Disease (3 papers), Alcohol Consumption and Health Effects (3 papers), Cardiovascular Function and Risk Factors (2 papers), Mitochondrial Function and Pathology (2 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper). The work is most often cited by research in Biochemistry (95 citations), Pharmacology (52 citations), Endocrinology, Diabetes and Metabolism (86 citations), Geriatrics and Gerontology (15 citations) and Cancer Research (62 citations). Ruolan Dong has collaborated with scholars based in China and United States. Frequent co-authors include Ling Tu, Xizhen Xu, Menglu Fu, Dao Wen Wang, Yan Yang, Jinlan Luo, Guang Chen, Zhihui Chen, Shuiqing Hu and Fan Wu. Their work appears in journals such as Cellular Physiology and Biochemistry, Journal of Ethnopharmacology, Frontiers in Pharmacology, Biomedicine & Pharmacotherapy and International Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.